v3.26.1
Note 16 - Summary of Discontinued Operations (Tables)
12 Months Ended
Dec. 31, 2025
Summary of Disposal Groups [Member]  
Notes Tables  
Disposal Groups, Including Discontinued Operations [Table Text Block]

For the year ended December 31, 2025

 

Avenova

Asset

Divestiture

   

PhaseOne

Divestiture

   

DERMA

doctor

Divestiture

   

China

NeutroPhase

product line

   

Total

 

Net income, net of taxes

  $ 10,509     $ 530     $     $ 42     $ 11,081  

Net increase in cash, cash equivalents and restricted cash

    10,550       541             42       11,133  

As of and for the year ended December 31, 2024

 

Avenova

Asset

Divestiture

   

PhaseOne

Divestiture

   

DERMA

doctor

Divestiture

   

China

NeutroPhase

product line

   

Total

 

Current assets

  $ 1,179     $ 54     $     $     $ 1,233  

Other assets

    9                         9  

Current liabilities

    1,147       43                   1,190  

Net income (loss), net of taxes

    2,445       71       (989 )           1,527  

Net increase (decrease) in cash, cash equivalents and restricted cash

    2,412       68       864       (45 )     3,299